美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

TrovaGene, Inc.

1.19

0.0000

成交量：- -

成交額：- -

市值：1,310.32萬

市盈率：-0.42

高：1.19

開：1.19

低：1.19

收：1.19

52周最高：3.46

52周最低：0.7010

股本：1,101.11萬

流通股本：963.56萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.8000

每股收益(LYR):-2.7966

淨資產收益率：-188.72%

總資產收益率：-76.48%

市淨率：1.79

市盈率(LYR):-0.43

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

TrovaGene, Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://trovageneoncology.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Trovagene, Inc.是一家出於發展階段的分子診斷公司，專註由專有產權的診斷技術的開發和市場推廣，這種技術在各種醫學診所用於患者/疾病的掃描和監視。公司主要的內部焦點是操作新型的尿液分子診斷平台，以促進在治療腫瘤領域的進步，外部焦點包括了在傳染病、移植醫療和產前診斷領域發展合作。公司於2002年4月26日以Used Kar Parts公司之名成立於弗羅里達。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TROV/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TROV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TROV\",,,,,undefined,":{"symbol":"TROV","market":"US","secType":"STK","nameCN":"TrovaGene, Inc.","latestPrice":1.19,"timestamp":1588881600000,"preClose":1.19,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":9635604,"shares":11011100,"eps":-2.8,"marketStatus":"盤後交易","change":0,"latestTime":"03-24 16:25:59 EDT","open":1.19,"high":1.19,"low":1.19,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.8,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1774396800000},"marketStatusCode":4,"symbolChange":{"newSymbol":"CRDF","executeDate":"2020-05-08"},"adr":0,"adrRate":0,"listingDate":1059624000000,"exchange":"NASDAQ","adjPreClose":1.19,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TROV\",,,,,undefined,":{"symbol":"TROV","floatShares":9635604,"roa":"-76.48%","roe":"-188.72%","lyrEps":-2.796607,"shares":11011100,"dividePrice":0,"high":1.19,"amplitude":0,"preClose":1.19,"low":1.19,"week52Low":0.701,"pbRate":"1.79","week52High":3.46,"institutionHeld":0,"latestPrice":1.19,"eps":-2.8,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.8,"open":1.19},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TROV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-05-08","symbol":"TROV","oldSymbol":"TROV","newSymbol":"CRDF","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1588910400000},{"market":"US","date":"2020-05-05","symbol":"TROV","fiscalQuarterEnding":"2020/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1588651200000,"reportTimeType":"","actualEps":-1.02},{"market":"US","date":"2020-02-27","symbol":"TROV","fiscalQuarterEnding":"2019/12","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1582779600000,"reportTimeType":"","actualEps":-0.51},{"market":"US","date":"2019-11-07","symbol":"TROV","fiscalQuarterEnding":"2019/09","expectedEps":-0.84,"name":null,"time":"","type":"earning","dateTimestamp":1573102800000,"reportTimeType":"","actualEps":-0.71},{"market":"US","date":"2019-08-08","symbol":"TROV","fiscalQuarterEnding":"2019/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1565236800000,"reportTimeType":"","actualEps":-0.79}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TROV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TROV\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://trovageneoncology.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0204},{"period":"1month","weight":-0.0494},{"period":"3month","weight":-0.0474},{"period":"6month","weight":-0.0087},{"period":"1year","weight":0.1621},{"period":"ytd","weight":-0.0389}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Trovagene, Inc.是一家出於發展階段的分子診斷公司，專註由專有產權的診斷技術的開發和市場推廣，這種技術在各種醫學診所用於患者/疾病的掃描和監視。公司主要的內部焦點是操作新型的尿液分子診斷平台，以促進在治療腫瘤領域的進步，外部焦點包括了在傳染病、移植醫療和產前診斷領域發展合作。公司於2002年4月26日以Used Kar Parts公司之名成立於弗羅里達。","exchange":"NASDAQ","name":"TrovaGene, Inc.","nameEN":"TrovaGene, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"TROV\",market:\"US\",,,undefined,":null}}